+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A low muscle mass increases mortality in compensated cirrhotic patients with sepsis

A low muscle mass increases mortality in compensated cirrhotic patients with sepsis

Liver International 38(5): 851-857

Severe infections and muscle wasting are both associated to poor outcome in cirrhosis. A possible synergic effect of these two entities in cirrhotic patients has not been previously investigated. We aimed at analysing if a low muscle mass may deteriorate the outcome of cirrhotic patients with sepsis. Consecutive cirrhotic patients hospitalized for sepsis were enrolled in the study. Patients were classified for the severity of liver impairment (Child-Pugh class) and for the presence of "low muscle mass" (mid-arm muscle circumference<5th percentile). The development of complication during hospitalization and survival was analysed. There were 74 consecutive cirrhotics with sepsis. Forty-three of these patients showed low muscle mass. In patients with and without low muscle mass, severity of liver disease and characteristics of infections were similar. Mortality tended to be higher in patients with low muscle mass (47% vs 26%, P = .06). A multivariate analysis selected low muscle mass (P < .01, HR: 3.2, IC: 1.4-4.8) and Child-Pugh C (P < .01, HR: 3.3, 95% IC: 1.5-4.9) as independent predictors of in-hospital mortality. In Child-Pugh A-B patients, mortality was higher in patients with low muscle mass compared with those without (50% vs 16%; P = .01). The mortality rate and the incidence of complications in malnourished patients classified in Child-Pugh A-B were similar to those Child-Pugh C. Low muscle mass worsen prognosis in cirrhotic patients with severe infections. This is particularly evident in patients with Child A-B cirrhosis in whom the coexistence of low muscle mass and sepsis caused a negative impact on mortality similar to that observable in all Child C patients with sepsis.

(PDF emailed within 0-6 h: $19.90)

Accession: 045985418

Download citation: RISBibTeXText

PMID: 29323441

DOI: 10.1111/liv.13691

Related references

Low skeletal muscle mass predicts early mortality in cirrhotic patients with acute variceal bleeding. Nutrition 42: 87-91, 2018

TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients. Plos One 11(11): E0166458, 2017

Risk factors for mortality in cirrhotic patients with sepsis. Hepatology International 5(3): 800-807, 2011

Hand-grip strength or muscle mass in cirrhotic patients: Who is the best?. Nutrition 22(2): 218-219, 2006

T-35 Cirrhotic patients fail to regain muscle mass after liver transplantation. Digestive and Liver Disease 45: S24-S25, 2013

Chronic anemia increases gastric blood perfusion in non-cirrhotic and cirrhotic patients. Gastroenterology 106(4 SUPPL ): A878, 1994

Development of a simple predictive model for decreased skeletal muscle mass in patients with compensated chronic liver disease. Hepatology Research 47(12): 1223-1234, 2016

Dementia Increases Severe Sepsis and Mortality in Hospitalized Patients With Chronic Obstructive Pulmonary Disease. Medicine 94(23): E967, 2015

Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis. Digestive and Liver Disease 50(8): 839-844, 2018

The Mortality in Emergency Department Sepsis Score as a Predictor of 1-Month Mortality among Adult Patients with Sepsis Weighing the Evidence. ISRN Emergency Medicine 2013: 1-6, 2013

Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality. Shock 27(5): 503-506, 2007

Performance of the Mortality in Emergency Department Sepsis score for predicting hospital mortality among patients with severe sepsis and septic shock. American Journal of Emergency Medicine 26(6): 689-692, 2008

Screening for hepato cellular carcinoma in well compensated cirrhotic patients. Gastroenterology 102(4 PART 2): A777, 1992

Limitations of compensated Jaffe creatinine assays in cirrhotic patients. Clinical Biochemistry 45(4-5): 320-325, 2012

Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients. Hepatology International 3(2): 384-391, 2009